Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
Line 45: | Line 45: | ||
|- | |- | ||
! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic disorders | ! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic disorders | ||
! align="center" style="background:#DCDCDC;" |[[Myelodysplastic syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Myelodysplastic syndrome (patient information)|Myelodysplastic syndrome]]<ref name="NatelsonPyatt2013">{{cite journal|last1=Natelson|first1=Ethan A.|last2=Pyatt|first2=David|title=Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog|journal=Advances in Hematology|volume=2013|year=2013|pages=1–11|issn=1687-9104|doi=10.1155/2013/309637}}</ref> | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* [[Bone marrow]] infiltration | * [[Bone marrow]] infiltration |
Revision as of 16:18, 17 September 2018
Differentiating Pancytopenia from Other Diseases
- There are no other mimickers of pancytopenia, as the diagnosis can be unequivocally established by laboratory testing (complete blood count).
Category | Condition | Etiology | Mechanism | Congenital | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | |||||||||||||||||||||||
Lab Findings | ||||||||||||||||||||||||||
Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | ||||||||||||||
Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Plt | HB | WBC | |||||||||||||||||||||
Hematologic disorders | Myelodysplastic syndrome[1] |
|
+ | + | − | ± | + | Elderly | Exposure to | + | + | Nl | + | + | ↓ | ↓ | ↓ |
|
|
Nl | Nl | Nl | Bone marrow examination + clinical manifestation |
| ||
Malignancies such as: |
|
+ | + | + | ± | ± | Any, more in adults |
|
+ | + | Nl | + | − | ↓ | ↓ | ↓ |
|
↑ | ↑ | Bone marrow examination |
| |||||
Myelofibrosis |
|
+ | + | − | + | + | Average 60 years old |
|
|
+ | + | Nl | + | − | ↓ | ↓ | ↓ |
|
↑ | ↑ | Bone marrow examination |
| ||||
Fanconi anemia | − | + | − | + | − | Rare autosomal recessive genetic disorder, higher in Ashkenazi Jews and Afrikaners in South Africa |
|
− | + | Nl | − | − |
|
↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Genetic studies | |||||
Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Gold standard | Associated findings | |
Aplastic anemia |
|
− | + | − | ± | ± | Biphasic (the young and the elderly) |
|
− | + | Nl | − | − | ↓ | ↓ | ↓ |
|
|
↑ | ↑ | Nl | Bone marrow examination +
laboratory findings |
||||
Paroxysmal nocturnal hemoglobinuria |
|
+ | + | − | − | + | Any age
(usually younger adults) |
|
|
− | − | Nl | − | − |
|
↓/Nl | ↓ | ↓/Nl |
|
Nl | Nl | Flow cytometry | ||||
Disseminated intravascular coagulation |
|
− | − | + | − | + | Any |
|
|
+ | + | ↓ | − | + | ↓/Nl | ↓ | ↓/Nl | NA | ↑ | ↑ | Lab findings |
| ||||
Dyskeratosis congenital/telomere biology disorders |
|
− | + | − | + | − | Rare genetic disorder |
|
|
− | + | Nl | − | + | ↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Clinical findings + genetic studies |
| |||
Shwachman-Diamond syndrome |
|
− | + | − | + | − | Rare genetic disorder |
|
|
− | + | Nl | − | + | ↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Clinical findings + genetic studies |
| |||
Immunology/
Rheumatology |
Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Gold standard | Associated findings |
SLE |
|
− | + | + | + | + | More in young females |
|
+ | + | Nl to ↓ | + | + | ↓ | ↓ | ↓ |
|
↑ | ↑ | Clinical findings + laboratory studies |
| |||||
Felty syndrome |
|
− | + | − | − | + | Rare autoimmune disease, more in females 50-70 years old |
|
+ | + | Nl | + | + |
|
↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Clinical findings + laboratory studies | ||||
Wiskott Aldrich syndrome |
|
− | + | − | + | − | Rare X-linked recessive disease |
|
− | + | Nl | − | − | ↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Genetic study |
| ||||
GATA2 deficiency |
|
− | + | − | + | − | Rare |
|
− | + | ↓ | + | + | − | ↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Genetic study |
| |||
Hemophagocytic lymphohistiocytosis |
|
− | + | − | + | − | Rare |
|
− | + | ↓ | + | + | − | ↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Genetic study |
| |||
GI disorders | Portal hypertension/cirrhosis |
|
− | − | + | − | + | Any | − | + | ↓ | + | + | − | ↓ | ↓ | ↓ |
|
↑ | ↑ | Nl | Clinical manifestation |
| |||
Storage diseases (eg, Gaucher) |
|
+ | − | + | + | − | Rare in children |
|
− | + | ↓ | + | + | − | ↓ | ↓ | ↓ |
|
||||||||
Infections | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Gold standard | Associated findings |
Sepsis |
|
+ | + | − | − | + | Any | + | ± | Nl to ↓ | − | ± | ↓/↑ | ↓ | ↓/↑ | NA | ↑ | ↑ | +
Depends on the etiology |
Clinical manifestation + culture |
| |||||
Viral infection such as HIV, hepatitis, Epstein-Barr virus |
|
− | + | + | − | + | Any |
|
+ | − | Nl | ± | ± |
|
↓ | ↓ | ↓ |
|
Nl | Nl | Clinical manifestation + lab tests |
| ||||
Nutritional | Megaloblastic anemia |
|
− | + | − | + | Any |
|
|
− | − | Nl | − | − | ↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Laboratory findings | NA | |||
Excessive alcohol |
|
− | + | − | − | + | Alcoholism |
|
|
− | − | Nl | + | + | ↓ | ↓ | ↓ |
|
↑ | ↑ | Nl | Clinical manifestation | ||||
Other nutritional deficiency such as copper deficiency, zinc toxicity |
|
− | + | − | − | + | Any |
|
|
− | − | Nl | − | − | ↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Laboratory findings | NA | |||
Malnutrition |
|
− | + | − | − | + | Any |
|
|
− | − | Nl | − | − | ↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Laboratory findings | NA | |||
Medications | Medications such as:
|
|
− | + | − | − | + | Patients with malignancy | − | + | Nl | − | − | − | ↓ | ↓ | ↓ |
|
↑ | ↑ | Hematuria | Clinical manifestation + exclusion of the other causes | ||||
Category | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Gold standard | Associated findings |
- ↑ Natelson, Ethan A.; Pyatt, David (2013). "Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog". Advances in Hematology. 2013: 1–11. doi:10.1155/2013/309637. ISSN 1687-9104.